Evidence map›Paper›PMID 40091434›Full record

ArticleAdvanced materials (Deerfield Beach, Fla.)2025

Formulation and Characterization of Novel Ionizable and Cationic Lipid Nanoparticles for the Delivery of Splice-Switching Oligonucleotides.

Miina Ojansivu, Hanna M G Barriga, Margaret N Holme, Stefanie Morf, James J Doutch, Samir El Andaloussi, Tomas Kjellman, Markus Johnsson, Justas Barauskas, Molly M Stevens

Abstract read
In one paragraph

Article in Advanced materials (Deerfield Beach, Fla.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Miina OjansivuDepartment of Medical Biochemistry and Biophysics, Karolinska Institute, Huddinge, Stockholm, 171 77, Sweden.ORCID https://orcid.org/0000-0002-5493-3530
Hanna M G BarrigaDepartment of Medical Biochemistry and Biophysics, Karolinska Institute, Huddinge, Stockholm, 171 77, Sweden.ORCID https://orcid.org/0000-0002-2530-5332
Margaret N HolmeDepartment of Medical Biochemistry and Biophysics, Karolinska Institute, Huddinge, Stockholm, 171 77, Sweden.ORCID https://orcid.org/0000-0002-7314-9493
Stefanie MorfDepartment of Medical Biochemistry and Biophysics, Karolinska Institute, Huddinge, Stockholm, 171 77, Sweden.
James J DoutchISIS Neutron and Muon Source, Rutherford Appleton Laboratory, Harwell Campus, Oxfordshire, OX11 0QX, UK.ORCID https://orcid.org/0000-0003-0747-8368
Samir El AndaloussiDivision of Biomolecular and Cellular Medicine, Department of Laboratory Medicine, Karolinska Institute, Huddinge, 14152, Stockholm, Sweden.ORCID https://orcid.org/0000-0003-4468-9113
Tomas KjellmanCamurus AB, Rydbergs torg 4, Lund, 224 84, Sweden.
Markus JohnssonCamurus AB, Rydbergs torg 4, Lund, 224 84, Sweden.
Justas BarauskasCamurus AB, Rydbergs torg 4, Lund, 224 84, Sweden.
Molly M StevensDepartment of Medical Biochemistry and Biophysics, Karolinska Institute, Huddinge, Stockholm, 171 77, Sweden.ORCID https://orcid.org/0000-0002-7335-266X

Funding

Cancerfonden 21-1762-Pj-01-HDiamond Light Source SM23642European Research Council 101001374European Union's Horizon 2020 research and innovation program 654000H2020 European Research Council 101001374H2020 Marie Skłodowska-Curie Actions 703666ISIS Neutron and Muon Source RB2010544Jane ja Aatos Erkon SäätiöMAXIV 20220250NSF DMR-0520547Oskar Huttusen säätiöOtto A. Malm LahjoitusrahastoPaulon SäätiöSwedish Foundation of Strategic Research, Industrial Research Centre "FoRmulaEx" IRC15-0065Swedish Research Council Starting Grant 2022-04592Vetenskapsrådet 4-258/2021
6 · The paper itself

Abstract

Despite increasing knowledge about the mechanistic aspects of lipid nanoparticles (LNPs) as oligonucleotide carriers, the structure-function relationship in LNPs has been generally overlooked. Understanding this correlation is critical in the rational design of LNPs. Here, a materials characterization approach is utilized, applying structural information from small-angle X-ray scattering experiments to design novel LNPs focusing on distinct lipid organizations with a minimal compositional variation. The lipid phase structures are characterized in these LNPs and their corresponding bulk lipid mixtures with small-angle scattering techniques, and the LNP-cell interactions in vitro with respect to cytotoxicity, hemolysis, cargo delivery, cell uptake, and lysosomal swelling. An LNP is identified that outperforms Onpattro lipid composition using lipid components and molar ratios which differ from the gold standard clinical LNPs. The base structure of these LNPs has an inverse micellar phase organization, whereas the LNPs with inverted hexagonal phases are not functional, suggesting that this phase formation may not be needed for LNP-mediated oligonucleotide delivery. The importance of stabilizer choice for the LNP function is demonstrated and super-resolution microscopy highlights the complexity of the delivery mechanisms, where lysosomal swelling for the majority of LNPs is observed. This study highlights the importance of advanced characterization for the rational design of LNPs to enable the study of structure-function relationships.

Indexed as

Drug CarriersLipidsNanoparticlesOligonucleotidesCationsHemolysisHumansLysosomesScattering, Small AngleCationsDrug CarriersLipidsOligonucleotidesdrug deliverylipid nanoparticleoligonucleotidesmall angle scatteringstochastic optical reconstruction microscopy

Identifiers

PMID40091434
PMCPMC12038542

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.